-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IHNzTtxJh7koIYv145K5EN1ShjcyVBpmsGVa5ExpLC66Uvog8nbRnSw3iIAQPif4 Yd92uLYLlThEx5qYTcfu3A== 0000904454-07-000043.txt : 20070208 0000904454-07-000043.hdr.sgml : 20070208 20070208104017 ACCESSION NUMBER: 0000904454-07-000043 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070208 DATE AS OF CHANGE: 20070208 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDCATH CORP CENTRAL INDEX KEY: 0001139463 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 562248952 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-62451 FILM NUMBER: 07590679 BUSINESS ADDRESS: STREET 1: 10720 SIKES PLACE SUITE 300 CITY: CHARLOTTE STATE: NC ZIP: 28277 BUSINESS PHONE: 7047086600 MAIL ADDRESS: STREET 1: 10720 SIKES PLACE SUITE 300 CITY: CHARLOTTE STATE: NC ZIP: 28277 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WELSH CARSON ANDERSON & STOWE VII LP ET AL CENTRAL INDEX KEY: 0001012089 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 320 PARK AVENUE STREET 2: SUITE 2500 CITY: NEW YORK STATE: NY ZIP: 10022 MAIL ADDRESS: STREET 1: 320 PARK AVENUE STREET 2: SUITE 2500 CITY: NEW YORK STATE: NY ZIP: 10022 SC 13G/A 1 s13ga_0207-2007medcath.txt SCHEDULE 13G/A CUSIP No. 58404W 10 9 Page 1 of 5 Pages SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 -------------------------- SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILES PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1)1 MedCath Corporation - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.01 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 58404W 10 9 - -------------------------------------------------------------------------------- (CUSIP Number) December 31, 2006 - -------------------------------------------------------------------------------- Date of Event Which Requires Filing of this Statement Check the appropriate box to designate the rule pursuant to which this Schedule is Filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) - -------- 1The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. CUSIP No. 58404W 10 9 Page 2 of 5 Pages - -------------------------------------------------------------------------------- 1) Name of Reporting Person Welsh, Carson, I.R.S. Identification Anderson & Stowe No. of Above Person VII, L.P. (Entities Only) - -------------------------------------------------------------------------------- 2) Check the Appropriate Box (a) [ X ] if a Member of a Group (b) [ ] - -------------------------------------------------------------------------------- 3) SEC Use Only - -------------------------------------------------------------------------------- 4) Citizenship or Place Delaware of Organization - -------------------------------------------------------------------------------- Number of 5) Sole Voting 3,540,801 shares Shares Beneficially Power of Common Stock Owned by Each Reporting Person With: -------------------------------------------------- 6) Shared Voting Power -0- -------------------------------------------------- 7) Sole Disposi- 3,540,801 shares of tive Power Common Stock -------------------------------------------------- 8) Shared Dis- positive Power -0- -------------------------------------------------- 9) Aggregate Amount Beneficially 3,540,801 shares of Owned by Each Reporting Person Common Stock - -------------------------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares - -------------------------------------------------------------------------------- 11) Percent of Class Represented by 16.9% Amount in Row (9) - -------------------------------------------------------------------------------- 12) Type of Reporting Person PN CUSIP No. 58404W 10 9 Page 3 of 5 Pages - -------------------------------------------------------------------------------- 1) Name of Reporting Person WCAS Healthcare I.R.S. Identification Partners, L.P. No. of Above Person (Entities Only) - -------------------------------------------------------------------------------- 2) Check the Appropriate Box (a) [ X ] if a Member of a Group (b) [ ] - -------------------------------------------------------------------------------- 3) SEC Use Only - -------------------------------------------------------------------------------- 4) Citizenship or Place Delaware of Organization - -------------------------------------------------------------------------------- Number of 5) Sole Voting 36,744 shares Shares Beneficially Power of Common Stock Owned by Each Reporting Person With: -------------------------------------------------- 6) Shared Voting Power -0- -------------------------------------------------- 7) Sole Disposi- 36,744 shares of tive Power Common Stock -------------------------------------------------- 8) Shared Dis- positive Power -0- -------------------------------------------------- 9) Aggregate Amount Beneficially 36,744 shares of Owned by Each Reporting Person Common Stock - -------------------------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares - -------------------------------------------------------------------------------- 11) Percent of Class Represented by 0.2% Amount in Row (9) - -------------------------------------------------------------------------------- 12) Type of Reporting Person PN CUSIP No. 58404W 10 9 Page 4 of 5 Pages AMENDMENT NO. 1 TO SCHEDULE 13G Reference is hereby made to the statement on Schedule 13G filed with the Securities and Exchange Commission on January 15, 2002 (the "Schedule 13G"). Terms defined in the Schedule 13G are used herein as so defined. The following Items of the Schedule 13G are hereby amended and restated as follows: Item 4 - Ownership. (a) Amount Beneficially Owned: WCAS VII: 3,540,801 shares of Common Stock WCAS HP: 36,744 shares of Common Stock (b) Percent of Class: WCAS VII: 16.9% WCAS HP: 0.2% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: WCAS VII: 3,540,801 shares of Common Stock WCAS HP: 36,744 shares of Common Stock (ii) shared power to vote or to direct the vote: -0- (iii) sole power to dispose or to direct the disposition of: WCAS VII: 3,540,801 shares of Common Stock WCAS HP: 36,744 shares of Common Stock (iv) shared power to dispose or to direct the disposition of: -0- CUSIP No. 58404W 10 9 Page 5 of 5 Pages Signature: After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. WELSH, CARSON, ANDERSON & STOWE VII, L.P. By: WCAS VII Partners, L.P., General Partner By /s/ Jonathan M. Rather ----------------------------------------- General Partner WCAS HEALTHCARE PARTNERS, L.P. By: WCAS HP Partners, General Partner By /s/ Jonathan M. Rather ----------------------------------------- Attorney-in-Fact Date: February 7, 2007 -----END PRIVACY-ENHANCED MESSAGE-----